Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan.

Chung Hua Min Kuo Wei Sheng Wu Chi Mien I Hsueh Tsa Chih. 1992 Nov;25(4):244-51. Unique Identifier : AIDSLINE MED/94109187
Yung CH; Chow MP; Hu HY; Tzeng JL; Wu YS; Lyou JY; Liu WT; Blood bank, Department of Medicine, Veterans General Hospital,; National Yang-Ming Medical College, Taipei, Taiwan, Republic of; China.

Abstract: The gelatin particle agglutination (GPA) test specific for antibody detection of human T-cell lymphotropic virus type 1 (HTLV-1) was used to screen 500 blood donors and 5000 physical-checkup individuals at Veterans General Hospital-Taipei. The positive rate of physical-checkup individuals and the blood donors was 0.18% (9/5000) and 0% (0/5000) respectively. Among the 9 GPA positive specimens, eight were confirmed to be positive by western blot analysis and a prevalence rate of 0.16% (8/5000). Seven of the nine GPA positive samples were also positive by indirect fluorescent antibody test and two of them had indeterminate results. Since GPA is less expensive, relatively simple and convenient, we recommend that GPA could be used as screening test for HTLV-1 infection of blood donors, followed by western blot method as a confirmatory test in blood bank.
Keywords: Adolescence Adult Aged Agglutination Tests *Blood Donors Blotting, Western Carrier State/EPIDEMIOLOGY/IMMUNOLOGY Female Fluorescent Antibody Technique Human HTLV-I Antibodies/*ANALYSIS HTLV-I Infections/EPIDEMIOLOGY/IMMUNOLOGY Male Middle Age *Physical Examination Retrospective Studies Taiwan/EPIDEMIOLOGY JOURNAL ARTICLEKWDadolescenceadultagedagglutinationtestsKWDblooddonorsblotting,westerncarrierstate/epidemiology/immunologyfemalefluorescentantibodytechniquehumanhtlv-iantibodies/KWDanalysishtlv-iinfections/epidemiology/immunologymalemiddleageKWDphysicalexaminationretrospectivestudiestaiwan/epidemiologyjournalarticle
940430
M9440875

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .